- Country: Ukraine
- Summary: Human Insulin (Short-Acting), Solution for Injection, 100 U/Ml, Bottle, 10 Ml; Human Insulin (Medium-Acting), Suspension for Injection, 100 U/Ml, Cartridge, 3 Ml Each; Insulin Asp...
- UAT Ref No: 131703645
- Deadline: 11 Dec 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: UAH 496344
- Notice Type: Tender
- Document Ref. No.: UA-2025-12-08-006387-a
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Human insulin (short-acting), solution for injection, 100 U/ml, bottle, 10 ml; Human insulin (Medium-acting), suspension for injection, 100 U/ml, cartridge, 3 ml each; Insulin aspart (Fast-acting), solution for injection, 100 U/ml, 3 ml each; Insulin glargine, solution for injection, 300 Unit/ml, 1.5 ml each; Insulin glulisine, solution for injection, 100 Units/ml, 3 ml each; Insulin degludec, solution for injection, 100 Units/ml, 3 ml each; Glucagen, lyophilisate for solution for injection 1 mg, bottle; Lidocaine, solution for injection, 20 mg/ml, 2 ml each; Lidocaine, solution for injection, 100 mg/ml, 2 ml each; Furosemide, solution for injection, 10 mg/ml, 2 ml each; Suxamethonium, solution for injection, 20 mg/ml, 5 ml each; Atracurium, solution for injection, 10 mg/ml, 2.5 ml each; Atracurium, solution for injection, 10 mg/ml, 5 ml each. (INN: Insulin (human), ATX: A10AB01; INN: Insulin (human), ATX: A10AC01; INN: Insulin aspart, ATH: A10AB05; MNN: Insulin glargine, ATH: A10AE04; MNN: Insulin glulisine, ATH: A10AB06; MNN: Insulin degludec, ATH: A10AE06; MNN: Glucagon, ATH: H04AA01; MNN: Lidocaine, ATH: N01BB02; MNN: Lidocaine, ATH: C01BB01; MNN: Furosemide, ATH: C03CA01; MNN: Suxamethonium, ATH: M03AB01; MNN: Atracurium, ATH: M03AC04; INN: Atracurium, ATX: M03AC04). (Nomenclature position code: DK 021:2015 33610000-9 Medicinal products for the treatment of diseases of the gastrointestinal tract and metabolic disorders; DK 021:2015 33610000-9 Medicinal products for the treatment of diseases of the gastrointestinal tract and disorders oh...
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINHuman Insulin (Short-Acting), Solution for Injection, 100 U/Ml, Bottle, 10 Ml; Human Insulin (Medium-Acting), Suspension for Injection, 100 U/Ml, Cartridge, 3 Ml Each; Insulin Asp... - Ukraine Tender
The COMMUNAL NON-PROFIT SOCIETY "REGIONAL MEDICAL CENTER OF FAMILY HEALTH" OF THE DNIPROPETROVSK REGIONAL COUNCIL, a Government sector organization in Ukraine, has announced a new tender for Human Insulin (Short-Acting), Solution for Injection, 100 U/Ml, Bottle, 10 Ml; Human Insulin (Medium-Acting), Suspension for Injection, 100 U/Ml, Cartridge, 3 Ml Each; Insulin Asp.... This tender is published on UkraineTenders under UAT Ref No: 131703645 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-12-11.
The estimated tender value is UAH 496344, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
